Alpha Healthcare Acquisition Corp. III (ALPA) Shareholders Approve Carmell Deal
Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) announced this afternoon that its shareholders approved its combination with drug developer Carmell at a special meeting held on July 11.
At yesterday’s meeting, a total of at least 15,511,079 shares, or 78.46%, of ALPA’s issued and outstanding common stock were present either in person or by proxy, which constituted a quorum.
...READ MORE